BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 46 filers reported holding BURNING ROCK BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,862,688 | -54.7% | 1,920,297 | +1.8% | 0.00% | -50.0% |
| Q2 2023 | $4,111,443 | +83043.4% | 1,885,983 | +7.2% | 0.00% | -33.3% |
| Q1 2023 | $4,945 | +78.7% | 1,759,877 | +43.1% | 0.00% | +50.0% |
| Q4 2022 | $2,767 | -99.9% | 1,229,869 | -17.5% | 0.00% | 0.0% |
| Q3 2022 | $3,563,000 | +2869.2% | 1,490,614 | +11442.6% | 0.00% | – |
| Q1 2022 | $120,000 | -96.9% | 12,914 | -96.8% | 0.00% | -100.0% |
| Q4 2021 | $3,901,000 | +122.5% | 409,315 | +317.6% | 0.00% | +100.0% |
| Q3 2021 | $1,753,000 | -39.1% | 98,022 | -8.3% | 0.00% | -50.0% |
| Q1 2021 | $2,879,000 | -9.4% | 106,941 | -22.3% | 0.00% | 0.0% |
| Q4 2020 | $3,179,000 | -24.7% | 137,606 | -18.2% | 0.00% | -60.0% |
| Q3 2020 | $4,219,000 | -41.6% | 168,223 | -37.1% | 0.01% | -50.0% |
| Q2 2020 | $7,227,000 | – | 267,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |